Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,150 | 17 | 80.4% |
| Travel and Lodging | $6,033 | 15 | 11.2% |
| Food and Beverage | $4,462 | 64 | 8.3% |
| Education | $25.67 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $47,524 | 53 | $0 (2019) |
| Medtronic Vascular, Inc. | $5,057 | 24 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $316.38 | 4 | $0 (2018) |
| PFIZER INC. | $237.90 | 10 | $0 (2023) |
| EKOS Corporation | $143.39 | 1 | $0 (2018) |
| Relypsa, Inc. | $125.00 | 1 | $0 (2017) |
| Cook Incorporated | $109.56 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $102.29 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $26.29 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.58 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $62.69 | 4 | PFIZER INC. ($62.69) |
| 2022 | $40.26 | 2 | PFIZER INC. ($29.68) |
| 2020 | $16.58 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16.58) |
| 2019 | $15,489 | 27 | Janssen Pharmaceuticals, Inc ($13,390) |
| 2018 | $18,947 | 29 | Janssen Pharmaceuticals, Inc ($17,215) |
| 2017 | $19,116 | 36 | Janssen Pharmaceuticals, Inc ($16,919) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/24/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/14/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, NURTEC ODT | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/23/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/16/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $83.58 | General |
| 12/15/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $51.92 | General |
| 12/14/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $137.78 | General |
| 12/14/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $101.90 | General |
| 12/14/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $93.64 | General |
| 12/13/2019 | Medtronic Vascular, Inc. | — | Travel and Lodging | In-kind items and services | $876.82 | General |
| 12/13/2019 | Medtronic Vascular, Inc. | — | Food and Beverage | In-kind items and services | $262.35 | General |
| 12/13/2019 | Medtronic Vascular, Inc. | — | Travel and Lodging | In-kind items and services | $254.40 | General |
| 12/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $75.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/30/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $110.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/19/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $579.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $163.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $79.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,128 | 4,518 | $902,145 | $340,635 |
| 2022 | 23 | 3,003 | 4,215 | $788,748 | $322,859 |
| 2021 | 22 | 3,115 | 4,442 | $829,726 | $353,696 |
| 2020 | 28 | 2,844 | 3,783 | $752,624 | $292,574 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 451 | 830 | $165,950 | $76,486 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 648 | 979 | $131,342 | $62,638 | 47.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 101 | 101 | $102,596 | $34,969 | 34.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 188 | 195 | $111,735 | $29,013 | 26.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 209 | 211 | $83,556 | $28,505 | 34.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 102 | 204 | $35,548 | $18,965 | 53.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 98 | 392 | $31,360 | $16,453 | 52.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 108 | $54,000 | $14,409 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $28,393 | $11,176 | 39.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 69 | 215 | $18,403 | $8,341 | 45.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 129 | $18,869 | $8,030 | 42.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 125 | 127 | $44,450 | $6,329 | 14.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 478 | 504 | $22,176 | $5,170 | 23.3% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 43 | 43 | $7,095 | $4,643 | 65.4% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 48 | 48 | $12,384 | $4,077 | 32.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 70 | 70 | $10,500 | $3,749 | 35.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 44 | $6,336 | $2,715 | 42.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 75 | 76 | $6,080 | $2,263 | 37.2% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 16 | 17 | $4,335 | $790.98 | 18.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 13 | 13 | $2,148 | $765.77 | 35.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 18 | 25 | $2,000 | $416.42 | 20.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 13 | 13 | $663.00 | $212.18 | 32.0% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 55 | 55 | $1,344 | $193.08 | 14.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 11 | $440.00 | $186.20 | 42.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 13 | 13 | $442.00 | $140.17 | 31.7% |
About Dr. George Bourganos, MD
Dr. George Bourganos, MD is a Specialist healthcare provider based in Woonsocket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700883477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Bourganos, MD has received a total of $53,672 in payments from pharmaceutical and medical device companies, with $62.69 received in 2023. These payments were reported across 99 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,150).
As a Medicare-enrolled provider, Bourganos has provided services to 12,090 Medicare beneficiaries, totaling 16,958 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Cardiovascular Disease
- Location Woonsocket, RI
- Active Since 07/07/2005
- Last Updated 01/20/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700883477
Products in Payments
- XARELTO (Drug) $47,524
- ELIQUIS (Drug) $507.27
- EKOSONIC (Device) $143.39
- Veltassa (Drug) $125.00
- Cook Medical AAA (Device) $109.56
- PRALUENT (Drug) $102.29
- VYNDAQEL (Drug) $29.68
- LifeVest (Device) $26.29
- CHANTIX (Drug) $17.33
- PRADAXA (Drug) $16.58
- PRALUENT (Biological) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Woonsocket
Kirit Desai, Md, MD
Specialist — Payments: $1,668
Mrs. Rashmi Benda, M.d, M.D
Specialist — Payments: $1,108
Cynthia Alves, Md, MD
Specialist — Payments: $686.37
Mohammed Arif, Md, MD
Specialist — Payments: $504.05
Mrs. Carol Christel
Specialist
Sarah Dansereau, Cota/L, COTA/L
Specialist